Objective: A recent task force has proposed the use of Sequential Organ Failure Assessment in clinical criteria for sepsis in adults. We sought to evaluate the predictive validity for PICU mortality of the Pediatric Logistic Organ Dysfunction-2 and of the "quick"
S
epsis is a leading cause of death in adults (1) as well as in children (2, 3) . The sepsis syndrome is characterized by nonspecific physiologic abnormalities that encompass a heterogeneous population, and thus, it remains difficult to define. Consensus criteria for pediatric sepsis that were proposed in 2005 to facilitate consistent enrollment across research studies (4) are widely adopted for use in clinical practice (5 ; Alain Duhamel, PhD 2, 3 ; Valérie Deken 2, 3 ; Bruno Grandbastien, MD, PhD 2, 4 ; Stéphane Leteurtre, MD, PhD 1, 2 ; on behalf of the Groupe Francophone de Réanimation et Urgences Pédiatriques (GFRUP) for severe sepsis in clinical practice may have important physiologic and outcome differences from those studied in clinical trials (2, (6) (7) (8) . Recently, a task force recommended, for adult patients, elimination of the terms sepsis syndrome, septicemia, and severe sepsis and instead defined sepsis as "life-threatening organ dysfunction due to a dysregulated host response to infection" (9) . Seymour et al (10) analyzing 1.3 million electronic health record encounters identified adults with suspected infection and observed that the predictive validity for in-hospital mortality of Sequential Organ Failure Assessment (SOFA) among ICU encounters was statistically greater than systemic inflammatory response syndrome (SIRS), which supports its use as a diagnostic criteria of sepsis. A simplified "quick" SOFA (qSOFA), including Glasgow Coma Scale, systolic blood pressure (SBP), and respiratory rate, had a good predictive validity for hospital mortality of patients outside the ICU.
The aim of this study was to evaluate the predictive validity for PICU mortality of the Pediatric Logistic Organ Dysfunction-2 (PELOD-2) and of the "quick" PELOD-2 (qPELOD-2 including Glasgow Coma Scale, SBP, or mean blood pressure [MBP] and heart rate) on day 1 in children admitted with suspected infection or septic shock in PICUs.
METHODS
We performed a secondary analysis of the database used for the development and validation of the PELOD-2 score (11), which included all consecutive children admitted between June 21, 2006, and October 31, 2007, into nine university-affiliated PICUs (eight in France and one in Belgium) that are members of the Groupe Francophone de Réanimation et Urgences Pédiatriques. Exclusion criteria were as follows: age 18 years old or older, premature at entry into PICU, pregnancy, total length of stay in PICU less than 4 hours, admission in a state of continuous cardiopulmonary resuscitation without achieving stable vital signs for at least 2 hours, transfer from another PICU, and admissions for scheduled procedures normally performed in other hospital locations.
Ethical Considerations
The study and its database were declared safe and were approved by the French authorities (Commission Nationale de l'Informatique et des Libertés) on February 7, 2007 . The study design was approved by the ethics committee of the Société de Réanimation de Langue Française on April 27, 2007. The requirement for consent was waived because the study was strictly observational.
Data Management
Data management, recording, and quality control processes are detailed in the article by Leteurtre et al (11) . In brief, patients were monitored until they died or were discharged from PICU. As for previously published severity and multiple organ dysfunction syndrome scores, the most abnormal value of each variable observed during day 1 was considered to calculate the PELOD-2 score on day 1 (d1PELOD-2). If a variable was not measured, we assumed that it was normal (i.e., the physician considered that the value of the variable was normal). Covariates and cutoffs were those of our previous publication (11).
For the current study, only children with infection as the cause of primary disease at entry (defined by physician diagnosis) were enrolled. Among them, those with hypotension-low SBP using age-adapted cutoffs of the PELOD (12) or low MBP using age-adapted cutoffs of the PELOD-2 (11)-and hyperlactatemia (serum lactate level > 2 mmol/L) were considered as having septic shock (9) . Two other lactate thresholds were considered (> 3 and > 4 mmol/L).
Also, similarly with what was proposed by the Third International Consensus Task Force (10, 13), we developed the quick d1PELOD-2 (d1qPELOD-2) including tachycardia (instead of tachypnea, not collected in the PELOD-2 database) that has a higher predictive value in children [14] ), hypotension (low SBP or MBP), and altered mentation (Glasgow < 11) (see (11, 12) for cutoffs) with a point score of 1 assigned to each variable (range, 0-3) ( Table 1 ). The PICU discharge status (death/survival) was used as the outcome dependent variable.
Statistical Analysis
The results are expressed by median and interquartile ranges (IQRs) for continuous variables and by frequencies and percentages for categorical variables. The comparisons of the d1PELOD-2 and d1qPELOD-2 scores between the two groups (dead/survivor) were performed by an unpaired Wilcoxon test. The discriminant power of the scores was estimated using the area under the curve (AUC) with 95% CIs, and an optimal cutoff was defined using the maximization of the Youden index; calibration was assessed using the Hosmer-Lemeshow chi-square test with a degree of freedom of 8 (p > 0.05 indicates a good calibration). We addressed the optimism bias using a bootstrap resampling method. We used a logistic regression to investigate the relation between d1PELOD-2, d1qPELOD-2, and mortality. As no imputation of variables not measured (and considered as normal, see above) was performed, we verified that mortality of children with variable not measured was very similar to that of children with normal values and very dissimilar to that of children with abnormal values. Statistical analyses were performed using SAS software version 9.3 (SAS Institute, Cary, NC). A p value of less than 0.05 was considered statistically significant.
RESULTS
This study included 862 children with suspected infection among 3,669 patients from the original database (11) (two with incomplete data being excluded). Contribution to sepsis mortality of each variable selected in the PELOD-2 score on this population of 862 children is depicted in Supplemental Table 1 (Supplemental Digital Content 1, http://links.lww.com/ PCC/A459). Characteristics of the population are reported in Table 2 . The mortality rate was 7.0% (60 deaths/862) close to the 6.0% of the whole population (222 deaths/3,671). The median d1PELOD-2 was 3 (IQR, 1-5) in children with suspected infection who survived and 13 (9) (10) (11) (12) (13) (14) (15) (16) (17) (18) in those who died (p = 0.0001). A d1PELOD-2 greater than or equal to 8 reflected an overall risk of mortality of 9.3% or more in children with suspected infection. In children having a low SBP with hyperlactatemia (n = 69), the d1PELOD-2 was 7.5 (5-11) in those who survived (66.7%) and 17 (13) (14) (15) (16) (17) (18) (19) (20) in those who died (33.3%) (p < 0.0001). In those having a low MBP with hyperlactatemia (n = 88), the d1PELOD-2 was 7 (5-10) in children who survived (69.3%) and 16 (13) (14) (15) (16) (17) (18) (19) (20) in those who died (30.7%) (p = 0.0001). The odds ratio of death per unit of the d1PELOD-2 was 1.50 (95% CI, 1.39-1.63) in our population as a whole ( Table 3) .
The AUC of the d1PELOD-2 score was 0.91 (95% CI, 0.86-0.96) in children with suspected infection, 0.88 (95% CI, 0.79-0.96) in those with low SBP and hyperlactatemia, and 0.91 (95% CI, 0.85-0.97) in those with low MBP and hyperlactatemia; after correction for the optimism bias, the AUC and 95% CI were strictly identical. The calibration p values were equal to 0.03, 0.36, and 0.49, respectively. Discrimination and calibration were not influenced by the lactate threshold considered (2, 3, or 4 mmol/L). When we considered three categories of age (< 1, 1-12, and > 12 yr), the AUC of the d1PELOD-2 was 0.93 (95% CI, 0.87-0.98) in children less than 1 year old and 0.88 (95% CI, 0.76-0.99) in those between 1 and 12 years; the AUC could not be determined in children of more than 12 years old because of the small sample size. Among nonsurvivors, 85.0% (sensitivity) had 8 or more d1PELOD-2 points, and 88.4% (specificity) of survivors had less than 8 d1PELOD-2 points; among patients with a score of 8 or more, 35.4% died (positive predictive value [Ppv]), whereas 98.8% of those having a score less than 8 survived (negative predictive value [Npv] ). Among patients with low SBP and lactatemia greater than 2 mmol/L, 91.3% (sensitivity) who died had 11 or more d1PELOD-2 points and 69.6% (specificity) of those who survived had less than 11 d1PELOD-2 points (Ppv, 60.0%; Npv, 94.1%). Among patients with low MBP and lactatemia greater than 2 mmol/L who died, 92.6% (sensitivity) had 11 or more d1PELOD-2 points and 75.4% (specificity) of those who survived had less than 11 d1PELOD-2 points (Ppv, 62.5%; Npv, 95.8%). Mortality of children with variables not measured was very dissimilar to those with abnormal values (all p < 0.001, except for MBP, but this is due to the small number of patients [n = 21] with variable not measured); for each variable included in the PELOD-2 score, when comparing mortality of children with variables not measured and that of children with normal values for this variable, after adjustment for the d1PELOD-2 (computed without the variable), we did not found any significant differences in mortality between the two groups, except for pupillary reaction and ventilation, but there were less than 5% of these variables not measured.
The median d1qPELOD-2 was as follows: 2 (IQR, 1-2 with SBP and 1.5-3 with MBP) in children who died and 1 (IQR, 0-1) in those who survived (p < 0.0001). Odds ratio of death per unit of the d1qPELOD-2 range from 4.93 (95% CI, 3.45-7.04) in patients with SBP to 5.43 (95% CI, 3.68-7.99) in patients with MBP. The d1qPELOD-2 was also a significant prognostic factor ( Table 3 ). The AUC of the d1qPELOD-2 was 0.82 (95% CI, 0.76-0.87) either with SBP or MBP; after correction for the optimism bias, the AUC and 95% CI were strictly identical. The calibration p values were equal to 0.89 and 0.72 with SBP and MBP, respectively. The AUC of the d1qPELOD-2 with SBP was 0.81 (95% CI, 0.75-0.87) in children less than 1 year old and 0.81 (95% CI, 0.71-0.92) in those between 1 and 12 years. The AUC of the d1qPELOD-2 with MBP was 0.80 (95% CI, 0.74-0.87) in children less than 1 year old and 0.82 (95% CI, 0.72-0.93) in those between 1 and 12 years. For these two scores, the AUC could not be determined for children of more than 12 years old because of the small sample size. Mortality according to d1qPELOD-2 is given in Table 4 . In brief, a d1qPELOD-2 score greater than or equal to 2 was associated with a mortality rate of 19.8% or more with d1qPELOD-2 SBP and 15.9% or more with d1qPELOD-2 MBP. Among deceased, 66.7% (sensitivity) had 2 or more d1qPELOD-2 SBP points and 85.3% (Specificity) of survivors had less than 2 d1qPELOD-2 SBP points (Ppv, 25.3%; Npv, 97.2%). Among deceased, 75.0% (sensitivity) had 2 or more d1qPELOD-2 MBP points and 79.1% (Specificity) of survivors had less than 2 d1qPELOD-2 MBP points (Ppv, 21.1%; Npv, 97.7%). (12) . Adaptations are themselves works protected by copyright. So in order to publish this adaptation, authorization must be obtained both from the owner of the copyright in the original work and from the owner of copyright in the translation or adaptation.
b
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DISCUSSION
In our patients with suspected infection and in those with associated shock, the predictive validity for PICU mortality of d1PELOD-2 was excellent. Furthermore, in comparison with what was reported by Seymour et al (10) in critically ill adults for the qSOFA (AUC, 0.66; 95% CI, 0.64-0.68), the d1qPELOD-2 had a good predictive validity for PICU mortality (AUC, 0.82, 95% CI, 0.76-0.87). Our patients had a median d1PELOD-2 of 3 (IQR, 2-6), suggesting a moderate severity, whereas those with shock had a median d1PELOD-2 between 9.5 (IQR, 5-13) (patients with low MBP and hyperlactatemia) and 11 (IQR, 6-15) (patients with low SBP and hyperlactatemia) ( Table 3 ). The mean Pediatric Index of Mortality 2 probability of death of the whole population was 6.2%, close to that reported by Schlapbach et al (15) (between 4.1% and 5.4% in children with invasive infection). This moderate severity is probably explained by the definition we used (physician diagnosis) like in the study by Weiss et al (6) who reported that sepsis cases diagnosed by physicians are less severely ill (8) . Several studies have reported a moderate level of agreement in the septic children diagnosed by physicians (clinical criteria), 2005 international consensus guidelines (research criteria), and international classification of diseases (administrative criteria): approximately one third of patients with sepsis diagnosed on clinical criteria would not have been included in studies on sepsis diagnosed on research criteria (6, 8) .
In 2014, the European Society of Intensive Care Medicine and the Society of Critical Care Medicine convened a task force who recommended for adults that 1) sepsis should be defined as life-threatening organ dysfunction caused by a dysregulated host response to infection and 2) for clinical operationalization, organ dysfunction can be represented by an increase in the SOFA score of 2 points or more. The task force also recommended, for out-of-hospital adult patients, the qSOFA as a new bedside clinical score to rapidly identify the risk of poor outcomes typical of sepsis (13) . In children, the PELOD score, proposed in 2003 (12) , has been updated in 2013 (PELOD-2) (11). Using its first version, we demonstrated that hazard ratio of death significantly increased with the severity of organ dysfunction, as estimated by the PELOD score, and the worst diagnostic category of septic state (16) .
A recent study compared children managed with severe sepsis in European and the U.S. PICUs to identify geographic variation, which may improve the design of future international studies (3). As there were no significant differences in morbidity and mortality between regions after adjusting for several factors, the authors suggested that future international clinical trials should use physiologic and laboratory criteria for severe sepsis to establish study eligibility without the requirement for PICU admission (3) . In this approach, the PELOD-2 could represent the precise physiologic and laboratory criteria used to identify pediatric sepsis.
Similarly to what was observed in adult patients with suspected infection, that is, a SOFA greater than or equal to 2 reflects a mortality risk greater than 10% and can represent organ dysfunction (13), a d1PELOD-2 greater than or equal to 8 reflected a mortality risk of approximately 10% or more in our children with suspected infection. This cutoff could, thus, be used to identify organ dysfunction in our PICU patients with suspected infection.
In this study, we defined hypotension as low SBP or low MBP either for identifying children with suspected infection and shock or for constructing the qPELOD-2 score. In fact, if MBP is used for initial resuscitation as recommended by the Surviving Sepsis Campaign (5, 13, 17) , SBP is used in the pediatric track and trigger systems as reviewed by Chapman et al (18) . Our study has some limitations. First, our database is almost 10 years old, and mortality should have improved due to changes in treatments; however, studies conducted on more recent database reported that the PELOD-2 score remains reflective of outcome (19, 20) . Second, as mentioned above, we did not screen our database with sepsis defined on the basis of 2005 International Sepsis Consensus Conference (4); however, the sensitivity of SIRS criteria has been criticized because they miss patients with infection and organ failure (6, 8, 21) . Third, our dataset included a small number of children over the age of 12 years (9.7%). Fourth, we did not use volume resuscitation in our definition of shock because this data were not available. Fifth, we only included children admitted in PICU, and thus, we did not consider children from different phases of acute care (out-of-hospital, emergency department, and hospital ward). Finally, we did not analyze different types of infection (community and nosocomial). These limitations reduce the generalizability of our findings and emphasize the need for future prospective multicenter studies.
CONCLUSION
Among children admitted to PICU with suspected infection, PELOD-2 of the first 24-hour period after admission was highly predictive of PICU mortality suggesting its use in clinical criteria for sepsis. This could help to standardize definitions and diagnostic criteria of pediatric sepsis. Further studies in other cohorts from different countries and including more patients are needed to confirm these results. Prospective studies will have also to determine the usefulness of the d1qPELOD-2 in children with suspected infection outside of the PICU or at admission. 
